Kunming Longjin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- Type of securities to be delisted: Renminbi ordinary shares, stock abbreviation: *ST Longjin, stock code: 002750, delisting date: June 27, 2025.
- The Company's stock will resume trading on June 6, 2025, and enter the delisting arrangement period, which lasts for fifteen trading days, with the expected last trading date being June 26, 2025.
- During the delisting arrangement period, the stock will trade on the risk warning board. On the first trading day of the delisting arrangement period, there will be no price limit; thereafter, the daily price limit will be 10%.
- Investors, securities companies, and other market participants are advised to settle stock pledge repurchase, agreed repurchase, margin financing, transfer, and Shenzhen Stock Connect transactions in a timely manner before the stock is delisted.
- For judicial freezing businesses expiring during the initial registration period of the delisting board after the stock is delisted, it is recommended that the competent authorities handle the renewal procedures in advance through the original execution assistance channels before the stock is delisted.
Kunming Longjin Pharmaceutical Co., Ltd. received the decision on the termination of its stock listing from the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") on May 28, 2025 (Shenzhen Stock Exchange Announcement [2025] No. 518). The SZSE has decided to terminate the listing of the Company's stock.
1. Type of Securities to be Delisted, Stock Abbreviation, Stock Code
- Type of securities: Renminbi ordinary shares
- Stock abbreviation: *ST Longjin
- Stock code: 002750